Hu Yao, Haessler Jeff, Lundin Jessica I, Darst Burcu F, Whitsel Eric A, Grove Megan, Guan Weihua, Xia Rui, Szeto Mindy, Raffield Laura M, Ratliff Scott, Wang Yuxuan, Wang Xuzhi, Fohner Alison E, Lynch Megan T, Patel Yesha M, Lani Park S, Xu Huichun, Mitchell Braxton D, Bis Joshua C, Sotoodehnia Nona, Brody Jennifer A, Psaty Bruce M, Peloso Gina M, Tsai Michael Y, Rich Stephen S, Rotter Jerome I, Smith Jennifer A, Kardia Sharon L R, Reiner Alex P, Lange Leslie, Fornage Myriam, Pankow James S, Graff Mariaelisa, North Kari E, Kooperberg Charles, Peters Ulrike
Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.
Clin Epigenetics. 2025 Apr 2;17(1):54. doi: 10.1186/s13148-025-01859-3.
Circulating lipid concentrations are clinically associated with cardiometabolic diseases. The phenotypic variance explained by identified genetic variants remains limited, highlighting the importance of searching for additional factors beyond genetic sequence variants. DNA methylation has been linked to lipid concentrations in previous studies, although most of the studies harbored moderate sample sizes and exhibited underrepresentation of non-European ancestry populations. In addition, knowledge of nongenetic factors on lipid profiles is extremely limited. In the Population Architecture Using Genomics and Epidemiology (PAGE) Study, we performed methylome-wide association analysis on 9,561 participants from diverse race and ethnicity backgrounds for HDL-c, LDL-c, TC, and TG levels, and also tested interactions between smoking or alcohol intake and methylation in their association with lipid levels. We identified novel CpG sites at 16 loci (P < 1.18E-7) with successful replication on 3,215 participants. One additional novel locus was identified in the self-reported White participants (P = 4.66E-8). Although no additional CpG sites were identified in the genome-wide interaction analysis, 13 reported CpG sites showed significant heterogeneous association across smoking or alcohol intake strata. By mapping novel and reported CpG sites to genes, we identified enriched pathways directly linked to lipid metabolism as well as ones spanning various biological functions. These findings provide new insights into the regulation of lipid concentrations.
循环脂质浓度在临床上与心脏代谢疾病相关。已识别的基因变异所解释的表型变异仍然有限,这凸显了寻找基因序列变异以外其他因素的重要性。在先前的研究中,DNA甲基化已与脂质浓度相关联,尽管大多数研究样本量适中,且非欧洲血统人群的代表性不足。此外,关于脂质谱非遗传因素的知识极其有限。在“利用基因组学和流行病学的人群结构”(PAGE)研究中,我们对9561名来自不同种族和族裔背景的参与者进行了全甲基化组关联分析,以研究高密度脂蛋白胆固醇(HDL-c)、低密度脂蛋白胆固醇(LDL-c)、总胆固醇(TC)和甘油三酯(TG)水平,并测试了吸烟或饮酒与甲基化之间在与脂质水平关联方面的相互作用。我们在16个位点鉴定出了新的CpG位点(P < 1.18E - 7),并在3215名参与者中成功进行了重复验证。在自我报告的白人参与者中又鉴定出一个新位点(P = 4.66E - 8)。尽管在全基因组相互作用分析中未鉴定出其他CpG位点,但13个已报道的CpG位点在吸烟或饮酒分层中显示出显著的异质性关联。通过将新的和已报道的CpG位点映射到基因,我们确定了与脂质代谢直接相关的富集途径以及跨越各种生物学功能的途径。这些发现为脂质浓度的调节提供了新的见解。